Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 2.84 1.07% 0.03
ACHN closed up 1.07 percent on Friday, May 24, 2019, on 1.34 times normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical ACHN trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Crossed Above 200 DMA Bullish 1.07%
Calm After Storm Range Contraction 1.07%
NR7 Range Contraction 1.07%
NR7-2 Range Contraction 1.07%
Fell Below 200 DMA Bearish 1.43%
MACD Bearish Signal Line Cross Bearish 1.43%
Calm After Storm Range Contraction 1.43%

Older signals for ACHN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company's drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Chemistry Biopharmaceutical Chemical Compounds Organic Compounds Infection Antiviral Drug Cyclopropanes Drug Therapies HCV Carbamates Hepatitis C Virus Ns3 Ns5a Protease Inhibitor Sulfonamides
Is ACHN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.98
52 Week Low 1.29
Average Volume 1,470,769
200-Day Moving Average 2.8052
50-Day Moving Average 3.0244
20-Day Moving Average 2.9155
10-Day Moving Average 2.911
Average True Range 0.1806
ADX 23.4
+DI 13.2113
-DI 20.9182
Chandelier Exit (Long, 3 ATRs ) 2.7082
Chandelier Exit (Short, 3 ATRs ) 3.2118
Upper Bollinger Band 3.1222
Lower Bollinger Band 2.7088
Percent B (%b) 0.32
BandWidth 14.179386
MACD Line -0.0401
MACD Signal Line -0.0289
MACD Histogram -0.0112
Fundamentals Value
Market Cap 388.4 Million
Num Shares 137 Million
EPS -0.50
Price-to-Earnings (P/E) Ratio -5.68
Price-to-Sales 33.83
Price-to-Book 1.40
PEG Ratio -0.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.00
Resistance 3 (R3) 3.00 2.95 2.97
Resistance 2 (R2) 2.95 2.91 2.95 2.96
Resistance 1 (R1) 2.89 2.88 2.92 2.89 2.95
Pivot Point 2.84 2.84 2.86 2.84 2.84
Support 1 (S1) 2.79 2.80 2.82 2.79 2.73
Support 2 (S2) 2.74 2.78 2.74 2.72
Support 3 (S3) 2.68 2.74 2.71
Support 4 (S4) 2.68